Please provide us with a few details so that we can match you with the right expert in your field.
*Required
Structural biology plays a pivotal role in drug discovery by providing comprehensive insights into the three-dimensional architectures of biological macromolecules, such as proteins and nucleic acids, and their interactions with drugs or other biomolecules.
Our in-house experts support you by applying their experience to:
Structure-based drug design (SBDD) is a critical part of the drug discovery process revealing which atoms are important for each interaction and supporting the design of new, more potent molecules. Using our in-house expertise and through trusted partnerships we can perform cryo-EM and X-ray crystallography to elucidate the atomic details of macromolecular targets.
To ensure high-quality sample preparation and increase the chances of successful structure determination, we also provide protein production services and a comprehensive quality control package. For the assessment of interacting partners, we also provide a suite of complimentary interaction analysis techniques, allowing you to assess the driving forces behind each molecular interaction.
X-ray crystallography is a powerful technique that can reveal the three-dimensional structure of proteins and can help drug discovery programs by providing detailed information on how potential drugs interact with their target proteins at the atomic level.
Cryo EM samples are prepared in solution, making it possible to solve structures of multiple states in a single sample. It is a powerful complementary technique to X-ray crystallography, as it can handle large, flexible complexes that do not typically crystallize.
We can provide crucial insight into the mechanism of action of therapeutics. Subsequently this drives cycles of the design-make-test-analyse (DMTA) drug discovery cycle, accelerating your drug development program.
Cryo EM can be used to visualise macromolecules in isolation or in complex with other molecules. We use Cryo EM for: